Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson’s disease at diagnosis

被引：0

作者：

Sheng-Peng Diao

Yang-Sha Zhuang

Ye-Qing Huang

Zhi-Hua Zhou

Ai-Qun Liu

Ming-Fan Hong

机构：

[1] The First Affiliated Hospital,Department of Neurology

[2] Jinan University,Department of Neurology, College of Clinical Medicine

[3] The First Affiliated Hospital,undefined

[4] Guangdong Pharmaceutical University,undefined

来源：

BMC Neurology | / 23卷

关键词：

Wilson’s disease; Neurological symptoms; Hepatic; Penicillamine; Zinc gluconate;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 61 条

[1]

Bandmann O(2015)Wilson's disease and other neurological copper disorders Lancet Neurol 14 103-113

[2]

Weiss KH(2017)Epidemiology and introduction to the clinical presentation of Wilson disease Handb Clin Neurol 142 7-17

[3]

Kaler SG(2015)Currently clinical views on genetics of Wilson’s disease Chin Med J 128 1826-1830

[4]

Lo C(2007)Wilson's disease Lancet 369 397-408

[5]

Bandmann O(2008)Diagnosis and treatment of Wilson disease: an update Hepatology 47 2089-2111

[6]

Chen C(2013)Brain metal accumulation in Wilson’s disease J Neurol Sci 329 55-58

[7]

Shen B(2010)Wilson disease Best Pract Res Clin Gastroenterol 24 531-539

[8]

Xiao JJ(2012)EASL clinical practice guidelines: Wilson’s disease J Hepatol 56 671-685

[9]

Ala A(2017)Wilson’s disease in China Neurosci Bull 33 323-330

[10]

Walker AP(2022)Wilson's disease- management and long term outcomes Best Pract Res Clin Gastroenterol 56–57 101768-325